SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-017870
Filing Date
2022-05-04
Accepted
2022-05-04 16:22:28
Documents
78
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q adpt-10q_20220331.htm   iXBRL 10-Q 2226914
2 EX-10.1 adpt-ex101_95.htm EX-10.1 129645
3 EX-31.1 adpt-ex311_6.htm EX-31.1 27591
4 EX-31.2 adpt-ex312_7.htm EX-31.2 27983
5 EX-32.1 adpt-ex321_9.htm EX-32.1 12136
6 EX-32.2 adpt-ex322_8.htm EX-32.2 13677
  Complete submission text file 0001564590-22-017870.txt   8522960

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA adpt-20220331.xsd EX-101.SCH 57622
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adpt-20220331_cal.xml EX-101.CAL 52420
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adpt-20220331_def.xml EX-101.DEF 182794
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20220331_lab.xml EX-101.LAB 423431
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20220331_pre.xml EX-101.PRE 342818
72 EXTRACTED XBRL INSTANCE DOCUMENT adpt-10q_20220331_htm.xml XML 1619699
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 22891838
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences